Nifty
:
23270.60
Sensex
:
74314.59
53.00 (0.23%)
-21.86 (-0.03%)
Nifty
Sensex
:
:
23270.60
74314.59
53.00 (0.23%)
-21.86 (-0.03%)

Acutaas Chemicals Ltd.

Pharmaceuticals & Drugs

Rating :
83/99

BSE: 543349 | NSE: ACUTAAS

NSE BSE
3315.10
17-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  3343
  •  3366
  •  3282
  •  3344.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  182520
  •  606472225
  •  3740
  •  1302

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 27,145.19
  • 70.28
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 26,946.85
  • 0.08%
  • 15.73

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.66%
  • 1.25%
  • 21.72%
  • FII
  • DII
  • Others
  • 21.61%
  • 17.79%
  • 4.97%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.65
  • 20.83
  • 23.13

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.44
  • 35.50
  • 30.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 40.31
  • 37.70
  • 102.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 63.82
  • 74.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.94
  • 8.64

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 39.84
  • 41.61

Earnings Forecasts:

(Updated: 12-09-2026)
Description
2026
2027
2028
2029
Adj EPS
91
8
26.03
42.91
P/E Ratio
36.43
414.39
127.36
77.26
Revenue
65.14
54.18
43.37
1315.76
EBITDA
1705.35
2165.04
2823.32
434.35
Net Income
586.33
740.95
974.86
315.54
ROA
424.49
542.26
699.76
17.84
P/B Ratio
-10.11
-5.90
-3.69
16.79
ROE
14.82
11.85
8.79
21.24
FCFF
22.43
22.82
24.03
-51.9
FCFF Yield
212.62
288.81
424.22
-0.17
Net Debt
0.71
0.96
1.41
-153.5
BVPS
-328.06
-561.48
-899.13
197.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
329.68
207.24
59.08%
432.75
308.48
40.28%
393.18
274.99
42.98%
306.20
246.73
24.10%
Expenses
216.60
156.33
38.55%
249.24
223.53
11.50%
242.53
206.32
17.55%
210.87
197.80
6.61%
EBITDA
113.07
50.91
122.10%
183.51
84.96
116.00%
150.65
68.67
119.38%
95.32
48.93
94.81%
EBIDTM
34.30%
24.57%
42.41%
27.54%
38.32%
24.97%
31.13%
19.83%
Other Income
1.80
15.94
-88.71%
11.11
5.78
92.21%
4.70
1.67
181.44%
9.84
8.44
16.59%
Interest
1.14
0.64
78.12%
1.19
0.60
98.33%
0.86
0.69
24.64%
0.58
0.50
16.00%
Depreciation
9.82
8.13
20.79%
9.63
7.30
31.92%
9.82
6.32
55.38%
8.40
6.83
22.99%
PBT
103.91
58.08
78.91%
183.80
82.84
121.87%
144.67
63.33
128.44%
96.18
50.04
92.21%
Tax
28.92
14.07
105.54%
49.52
20.12
146.12%
38.45
17.89
114.92%
24.32
12.47
95.03%
PAT
74.99
44.01
70.39%
134.28
62.72
114.09%
106.22
45.45
133.71%
71.85
37.57
91.24%
PATM
22.75%
21.24%
31.03%
20.33%
27.02%
16.53%
23.47%
15.23%
EPS
9.07
5.41
67.65%
16.09
3.82
321.20%
13.19
5.49
140.26%
8.82
4.56
93.42%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
1,461.81
1,339.37
1,006.88
717.47
616.73
520.13
340.61
239.64
238.51
188.22
160.26
Net Sales Growth
40.91%
33.02%
40.34%
16.33%
18.57%
52.71%
42.13%
0.47%
26.72%
17.45%
 
Cost Of Goods Sold
607.83
565.96
552.18
411.69
330.89
272.83
179.68
128.91
148.43
112.95
95.00
Gross Profit
853.98
773.41
454.69
305.79
285.84
247.30
160.92
110.73
90.08
75.27
65.27
GP Margin
58.42%
57.74%
45.16%
42.62%
46.35%
47.55%
47.24%
46.21%
37.77%
39.99%
40.73%
Total Expenditure
919.24
858.97
774.80
588.98
494.13
414.96
260.45
198.63
196.43
157.70
137.13
Power & Fuel Cost
-
37.36
30.12
25.82
22.28
21.40
5.26
4.54
4.14
1.27
1.00
% Of Sales
-
2.79%
2.99%
3.60%
3.61%
4.11%
1.54%
1.89%
1.74%
0.67%
0.62%
Employee Cost
-
117.57
83.66
63.11
48.84
41.37
21.01
17.81
11.75
9.89
7.38
% Of Sales
-
8.78%
8.31%
8.80%
7.92%
7.95%
6.17%
7.43%
4.93%
5.25%
4.61%
Manufacturing Exp.
-
66.88
51.77
47.35
46.98
49.66
41.32
34.60
16.94
19.87
15.42
% Of Sales
-
4.99%
5.14%
6.60%
7.62%
9.55%
12.13%
14.44%
7.10%
10.56%
9.62%
General & Admin Exp.
-
30.66
19.23
12.97
9.93
7.30
4.46
4.72
5.71
8.59
13.68
% Of Sales
-
2.29%
1.91%
1.81%
1.61%
1.40%
1.31%
1.97%
2.39%
4.56%
8.54%
Selling & Distn. Exp.
-
31.31
29.63
19.88
26.49
19.92
7.01
5.79
6.04
3.97
3.92
% Of Sales
-
2.34%
2.94%
2.77%
4.30%
3.83%
2.06%
2.42%
2.53%
2.11%
2.45%
Miscellaneous Exp.
-
9.23
8.22
8.15
8.71
2.49
1.72
2.26
3.43
1.16
3.92
% Of Sales
-
0.69%
0.82%
1.14%
1.41%
0.48%
0.50%
0.94%
1.44%
0.62%
0.46%
EBITDA
542.55
480.40
232.08
128.49
122.60
105.17
80.16
41.01
42.08
30.52
23.13
EBITDA Margin
37.11%
35.87%
23.05%
17.91%
19.88%
20.22%
23.53%
17.11%
17.64%
16.22%
14.43%
Other Income
27.45
41.59
16.93
7.49
4.32
2.76
1.38
2.84
0.38
2.96
0.21
Interest
3.77
3.27
6.22
5.94
2.41
6.41
5.62
5.59
4.75
3.23
3.30
Depreciation
37.67
35.99
26.62
16.06
12.34
10.08
4.19
3.52
2.60
1.91
1.37
PBT
528.56
482.73
216.16
113.99
112.17
91.45
71.73
34.75
35.11
28.35
18.68
Tax
141.21
126.36
55.75
33.19
28.88
19.50
17.73
7.28
11.81
9.85
6.63
Tax Rate
26.72%
26.18%
25.79%
40.52%
25.75%
21.32%
24.72%
20.95%
33.64%
34.74%
35.49%
PAT
387.34
356.26
158.72
42.78
83.29
71.95
54.00
27.47
23.30
18.50
12.05
PAT before Minority Interest
386.22
356.37
160.42
48.71
83.29
71.95
54.00
27.47
23.30
18.50
12.05
Minority Interest
-1.12
-0.11
-1.70
-5.93
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
26.50%
26.60%
15.76%
5.96%
13.51%
13.83%
15.85%
11.46%
9.77%
9.83%
7.52%
PAT Growth
104.13%
124.46%
271.01%
-48.64%
15.76%
33.24%
96.58%
17.90%
25.95%
53.53%
 
EPS
47.29
43.50
19.38
5.22
10.17
8.79
6.59
3.35
2.84
2.26
1.47

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
1,653.56
1,309.63
674.00
593.96
522.27
166.93
111.81
82.22
57.68
38.99
Share Capital
40.94
40.93
36.88
36.44
36.44
31.50
10.50
10.50
1.50
1.50
Total Reserves
1,609.51
1,268.59
634.81
557.52
485.84
135.43
101.31
71.72
56.18
37.49
Non-Current Liabilities
42.40
26.93
127.98
10.13
7.29
80.29
25.46
25.37
32.73
15.09
Secured Loans
0.00
0.00
113.64
0.63
0.59
71.82
12.59
11.60
28.10
14.03
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.82
7.31
10.50
3.68
0.47
Long Term Provisions
4.59
2.55
1.32
0.68
0.44
4.37
2.44
1.14
0.98
0.63
Current Liabilities
230.81
202.25
285.17
162.85
129.32
166.04
94.61
105.56
65.00
54.82
Trade Payables
153.91
156.05
134.61
142.05
118.42
84.78
51.45
68.39
47.76
38.43
Other Current Liabilities
12.44
13.48
64.78
6.64
4.88
34.62
8.84
10.52
3.36
4.99
Short Term Borrowings
26.49
8.18
72.59
2.77
0.00
44.53
33.92
26.14
9.48
9.06
Short Term Provisions
37.98
24.54
13.20
11.39
6.02
2.12
0.41
0.51
4.40
2.34
Total Liabilities
1,983.96
1,549.26
1,095.91
766.94
658.88
413.26
231.88
213.15
155.41
108.90
Net Block
744.86
570.39
427.16
258.95
204.53
186.31
85.19
78.78
31.54
27.76
Gross Block
862.09
651.64
481.95
297.69
231.14
202.83
97.78
90.97
41.13
35.45
Accumulated Depreciation
117.23
81.25
54.79
38.74
26.60
16.52
12.59
12.20
9.60
7.69
Non Current Assets
1,102.69
757.63
602.60
309.81
229.31
190.83
104.93
85.41
66.45
42.30
Capital Work in Progress
332.32
130.28
125.42
29.80
2.96
0.20
11.71
1.96
30.32
11.42
Non Current Investment
0.20
0.20
0.20
1.65
1.71
1.43
1.73
1.64
2.55
1.43
Long Term Loans & Adv.
24.42
55.88
48.59
17.20
14.23
1.65
2.68
2.24
0.76
0.54
Other Non Current Assets
0.91
0.88
1.23
2.21
5.87
1.25
3.63
0.79
1.28
1.15
Current Assets
881.27
791.64
493.30
457.13
429.57
216.23
121.04
124.10
87.19
66.48
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
231.32
179.94
156.73
119.17
112.17
60.36
52.34
38.67
27.39
19.72
Sundry Debtors
362.56
290.49
206.35
230.26
163.70
120.69
56.40
76.09
49.97
36.49
Cash & Bank
224.83
248.93
53.31
58.67
99.55
2.68
3.82
0.49
1.17
3.58
Other Current Assets
62.54
3.07
4.44
7.95
54.14
32.49
8.47
8.85
8.67
6.68
Short Term Loans & Adv.
57.24
69.20
72.47
41.08
43.05
20.76
8.31
8.53
8.54
6.29
Net Current Assets
650.46
589.39
208.13
294.28
300.25
50.19
26.42
18.54
22.19
11.66
Total Assets
1,983.96
1,549.27
1,095.90
766.94
658.88
413.26
231.89
213.16
155.41
108.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
292.17
118.34
125.17
65.53
-11.93
27.96
27.08
8.46
28.54
9.86
PBT
482.73
216.16
81.90
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Adjustment
14.13
18.92
49.79
14.09
13.64
8.02
10.17
4.43
4.07
2.66
Changes in Working Capital
-93.11
-70.01
17.82
-36.28
-94.21
-37.61
-9.44
-16.54
12.56
-7.53
Cash after chg. in Working capital
403.74
165.08
149.52
89.98
10.88
42.14
35.49
16.24
35.31
12.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-111.57
-46.74
-24.35
-24.45
-22.81
-14.18
-8.41
-7.78
-6.78
-2.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-265.94
-223.94
-365.39
-33.04
-120.72
-101.21
-23.94
-25.32
-18.61
-14.23
Net Fixed Assets
-232.79
-170.91
-245.28
-83.19
-30.11
-90.85
-31.67
-21.20
-14.99
Net Investments
-49.93
0.00
-34.28
-0.05
-0.16
-5.35
-6.72
-5.77
-4.04
Others
16.78
-53.03
-85.83
50.20
-90.45
-5.01
14.45
1.65
0.42
Cash from Financing Activity
4.10
261.12
239.36
-12.25
140.26
72.11
0.19
14.62
-7.11
4.37
Net Cash Inflow / Outflow
30.33
155.52
-0.86
20.24
7.61
-1.14
3.33
-2.23
2.82
-0.01
Opening Cash & Equivalents
185.22
29.70
30.53
10.30
2.68
3.82
0.49
3.14
0.32
0.33
Closing Cash & Equivalent
215.55
185.22
29.70
30.53
10.30
2.68
3.82
0.90
3.14
0.32

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
201.59
79.98
91.06
163.01
143.34
17.01
106.49
372.75
259.14
181.71
ROA
20.17%
12.13%
5.23%
11.68%
13.42%
16.74%
12.34%
13.99%
12.04%
13.87%
ROE
24.08%
16.19%
7.70%
14.92%
21.07%
39.63%
28.31%
39.03%
36.44%
46.43%
ROCE
32.42%
20.14%
11.81%
20.45%
23.85%
33.01%
26.25%
38.24%
35.91%
35.54%
Fixed Asset Turnover
1.77
1.78
1.84
2.33
2.40
2.27
2.54
4.92
5.32
6.20
Receivable days
88.98
90.06
111.06
116.58
99.79
94.89
100.90
83.83
82.89
86.20
Inventory Days
56.04
61.02
70.18
68.46
60.54
60.39
69.31
45.68
44.82
46.64
Payable days
99.95
96.06
122.64
143.66
135.92
138.36
169.65
99.64
97.78
86.73
Cash Conversion Cycle
45.07
55.02
58.60
41.38
24.41
16.92
0.56
29.87
29.93
46.11
Total Debt/Equity
0.02
0.01
0.32
0.01
0.00
0.85
0.53
0.78
0.68
1.09
Interest Cover
148.71
35.76
14.79
47.50
15.27
13.77
7.22
9.79
6.67
7.92

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Acutaas Chemicals inaugurates pilot plant in Surat
    4th Sep 2026, 14:29 PM

    The pilot plant will support the R&D for new product trials and validations

    Read More
  • Acutaas Chemicals’ arm inaugurates semiconductor chemicals manufacturing plant in South Korea
    28th Aug 2026, 11:51 AM

    The plant was completed within 11 months of its groundbreaking on September 29, 2025

    Read More
  • Acutaas Chemicals gets nod for Rs 212 crore capital expenditure plan
    24th Aug 2026, 12:30 PM

    The project targets a production capacity of up to 81,000 metric tonnes per annum for new electronic grade chemicals

    Read More
  • Acutaas Chemicals - Quarterly Results
    25th Jul 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.